The Importance of Risk Assessment as a Foundation of RBQM
Author: Rod Rahimi, Solution Expert at CluePoints. Risk assessment is the foundation of Risk Based Quality Management (RBQM). The adoption of statistics to assist with…
Read More
CluePoints Appoints Andy Cooper as New Chief Executive Officer
New CEO brings a combination of experience and drive as CluePoints rapidlyscales its RBQM and Data Quality Oversight offerings King of Prussia, PA – December…
Read More
10 reasons people like working at CluePoints
From the friendly, supportive culture to making a difference in people’s lives, there are a million and one reasons why people love working at CluePoints.…
Read More
RBQM and ML: Perfect Partners for More Efficient Clinical Trials
Artificial intelligence (AI) and risk-based quality management (RBQM) are growing trends in pharma – and the two go together like strawberries and cream. For decades,…
Read More
Twin Peaks: 10 years of CluePoints and Risk-Based Monitoring
It’s been ten years since CluePoints set out on a journey to let clinical trial data speak for itself – and what a journey it…
Read More
RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials
Risk-Based Quality Management: A front row seat to a decade of transformation King of Prussia, PA – October 12th, 2022: Risk-based quality management (RBQM) solutions…
Read More
The Inaugural ACDM AI & ML Conference Promises to Move the Dial
CluePoints is excited to participate in a brand-new annual conference designed to help the research sector level up its artificial intelligence (AI) and machine learning…
Read More
Natural Language Processing Improves Risk Signal Documentation in Clinical Trials
Authors: Sylviane de Viron, Data and Knowledge Manager Nicolas Huet, Machine Learning Manager Central monitoring helps sponsors proactively identify quality issues in clinical trials. To…
Read More
Federated Learning & Risk-Based Data Management – The Future of Smart Healthcare
According to CluePoints Senior Vice President John Hall, “Federated learning is a critical evolution in the application of machine learning (ML) in healthcare and clinical…
Read More
Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future
CluePoints Hosts RBQM Live 2022 as the Premier Event Sponsor King of Prussia, PA – Aug 30th, 2022: Industry-leading risk-based study execution and data quality…
Read More
Events
Find out where we’re headed next.
Featured Whitepaper
ICH E6 (R2)
Summary
Paper
Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.
Featured Webinar
ICH E6 (R2)
Webinar
Series
This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.
We're Kind of a Big Deal.
6,000
Platform Users
1,000
Studies De-Risked
100,000
Issues Detected